[Asia Economy Reporter Park Hyungsoo] DreamCIS, which is pursuing a listing on the KOSDAQ market, attracted 1.4 trillion KRW in public offering subscription.


According to the financial investment industry on the 13th, DreamCIS recorded a subscription competition rate of 669.217 to 1 for the public offering targeting general investors.


The subscription deposit reached approximately 1.3509 trillion KRW.


Previously, in the institutional demand forecast, it recorded a competition rate of 926.11 to 1. The public offering price was set at 14,900 KRW, the upper limit of the desired price range of 13,000 to 14,900 KRW.


Founded in 2004, DreamCIS is a Contract Research Organization (CRO) that conducts clinical trials for biopharmaceuticals. It is scheduled to be listed on the KOSDAQ on the 22nd.



Since March, when the domestic stock market plunged due to the spread of the novel coronavirus infection (COVID-19), DreamCIS is the first company to pursue an Initial Public Offering (IPO). There were no new listings on the KOSPI and KOSDAQ markets last month.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing